Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.
about
Mechanism-Oriented Therapy of Irritable Bowel SyndromeRecent advances in understanding and managing cholestasisChemoproteomic Profiling of Bile Acid Interacting ProteinsThe response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.Intestinal transport and metabolism of bile acidsIrritable bowel syndrome: an integrated explanatory model for clinical practice.How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomes.Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies.Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 ActionThe Farnesoid X Receptor: Good for BAD.Incidence and predictive factors for positive 75SeHCAT test: improving the diagnosis of bile acid diarrhoea.A variant of FGF19 for treatment of disorders of cholestasis and bile acid metabolismReduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons.Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants.Editorial: diagnosing bile acid diarrhoea with blood tests.Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea.Randomised clinical trial: colestyramine vs. hydroxypropyl cellulose in patients with functional chronic watery diarrhoea.Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature.
P2860
Q26747875-6864E126-9E57-4D81-8907-3F068EB00496Q26748537-8F1D1318-F6B8-4AB9-B7BD-61552C7FAE05Q33731122-E6E09A0C-33B5-4232-A7B1-EF6E508FB0E0Q34444158-39295C58-65E1-410F-8B15-CC4A9CC3D136Q35247159-13AE3BBB-F4AD-44AC-A3A2-342646E81659Q35565145-3C3FB150-5161-4E92-9EC2-DE8D5FA97971Q37598045-1D1D1862-7DC7-4FA5-A45C-69BDB1498714Q38381588-635CE84B-C2C4-4186-928B-1BEEE1D2BE43Q38723347-54249A95-30EB-4A8F-844D-9BB02F205447Q39125255-371D1484-063C-44FB-A381-104D5F603C5DQ39170275-3301199A-47A0-477D-A392-6E3269FB8627Q40858310-59E63FDB-2911-4BA3-9D31-8A0BA9D32642Q42494201-4AE8C6D3-0FD5-4ECA-B85E-79915A78A4ABQ47237068-40631545-19B6-4AC0-B39E-5BB7EBE97EA3Q48112817-398BDBD4-DB11-48C1-89D5-0F04A19ABF8DQ48319424-62B37E91-5442-4D26-BF7C-61D5411928F6Q50448468-6F957DE6-7DC9-4712-A24C-0D15A5D10D9BQ50535134-769D54C8-CF11-4539-8E13-E74C10DDEBA8Q55345479-B4AEFE70-F048-4EFA-9592-E5DF11059F13
P2860
Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.
@en
type
label
Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.
@en
prefLabel
Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.
@en
P2860
P356
P1476
Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.
@en
P2093
Julian R F Walters
P2860
P2888
P304
P356
10.1038/NRGASTRO.2014.32
P407
P50
P577
2014-03-25T00:00:00Z
P6179
1018601774